Updated April 13, 2009
A study of 82 patients suffering psoriasis treated with homeopathy in primary care over a period of two years shows significant improvement in their quality of life and reduction in their psoriasis symptoms. Many of the patients had suffered psoriasis for as long as 15 years and had previously unsuccessfully tried conventional treatments. The full paper of the study is published in the Journal of the European Academy of Dermatology and Venereology, a conventional medical Journal.
Objective To evaluate details and effects of homeopathic treatment in patients with psoriasis in usual medical care.
Methods Primary care patients were evaluated over 2 years using standardized questionnaires, recording diagnoses and complaints severity, health-related quality of life (QoL), medical history, consultations, all treatments, and use of other health services.
Results Forty-five physicians treated 82 adults, 51.2% women, aged 41.6 ± 12.2 (mean ± SD) years. Patients had psoriasis for 14.7 ± 11.9 years; 96.3% had been treated before. Initial case taking took 127 ± 47 min. The 7.4 ± 7.4 subsequent consultations (duration: 19.4 ± 10.5 min) cumulated to 169.0 ± 138.8 min. Patients received 6.0 ± 4.9 homeopathic prescriptions. Diagnoses and complaints severity improved markedly with large effect sizes (Cohen’s d= 1.02–2.09). In addition, QoL improved (SF-36 physical component score d = 0.26, mental component score d = 0.49), while conventional treatment and health service use were considerably reduced.
Conclusions: Under classical* homeopathic treatment, patients with psoriasis improved in symptoms and QoL.
Homeopaths have successfully treated psoriasis with no side effects. For over 200 years homeopaths have demonstrated strategies for treating and dealing with it. Hahnemann the original founder of homeopathy, even discussed this disease as a consequence of various genetic influences. Recent studies showing homeopathy’s safety and efficacy comes on the heels of the United States Food and Drug Administration warning that taking the psoriasis drug Raptiva could result in serious brain infections and even death.
The Food and Drug Administration cited three confirmed cases, and a possible fourth, of people diagnosed with progressive multifocal leukoencephalopathy (PML) after being treated with Raptiva.
“Three of those patients have died,” the FDA said in a public health advisory. “All four patients were treated with the drug for more than three years.”
None was receiving other treatments that suppress the immune system.
Raptiva’s product labeling was revised in October to highlight a boxed warning about the risks of life-threatening infections, including PML.
“At that time, the FDA directed Genentech, the manufacturer, to develop a risk evaluation and mitigation strategy (REMS) to include a medication guide to educate patients about the drug’s risks,” the FDA’s advisory says.
In the advisory, issued Thursday, the FDA highlighted the confirmed cases and promised to “take appropriate steps” to ensure that Raptiva’s risks do not outweigh its benefits.
The FDA also said it will ensure that patients “are clearly informed of the signs and symptoms of PML” and that health care professionals “carefully monitor patients for the possible development of PML.”
Interestingly, the drug has not been discontinued- just a warning to doctors to watch out if they find their patients start developing this serious life threatening condition as a result of taking the drug.
With a general study showing that homeopathy is safe and for the millions daily who use it, homeopathy is a logical choice for individuals suffering with such a challenging condition as psoriasis.
*Classical homeopathy is the selection of an individual homeopathic remedy for each person even though they may suffer from the same disease, after a full multi-leveled intake interview. See here for more on homeopathy and how to find a good homeopath.